SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

May 03, 2016 at 09:00 | Source: Moneycontrol.com
Nutraplus India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 02, 2016, has considered and approved the conversion of 4,80,000 Warrants held by Mr. Mukesh Naik (Promoter) into equivalent number of Equity Shares of Rs. 10/- each.
May 02, 2016 at 14:42 | Source: Moneycontrol.com
Caplin Point Laboratories Ltd has informed BSE that Mr. D. P. Mishra, Whole-time Director of the Company resigned from the position of the Whole-time Director from the Close of business hours on April 30, 2016 (Since, his term of Whole-time Director expires on that date) and he continues to be a Director of the Company.
May 02, 2016 at 13:55 | Source: Moneycontrol.com
Themis Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 11, 2016 to consider, the Audited Financial Results for the quarter and Year ended on March 31, 2016.
May 02, 2016 at 13:23 | Source: Moneycontrol.com
Vikram Thermo India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 02, 2016, has recommended dividend on equity shares at 15 percent on Equity Shares of Rs. 10/- each amounting Rs. 1.5/- per share, on paid up Equity Capital of the Company.
Apr 26, 2016 at 22:08 | Source: PTI
The Delhi High Court has allowed pharma firms, Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd, to continue with manufacture and marketing of their breast cancer drug under their brand names 'CANMAb' and 'HERTRAZ'.
Apr 26, 2016 at 16:37 | Source: Moneycontrol.com
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 06, 2016, inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 01, 2016 to March 31, 2016 and for the financial year ended March 31, 2016.
Apr 26, 2016 at 16:26 | Source: Moneycontrol.com
Hester Biosciences Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on May 07, 2016, to consider the Audited Standalone and Consolidated Financial Results for the quarter and year ended on March 31, 2016.
Apr 26, 2016 at 16:04 | Source: Moneycontrol.com
Alembic Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 26, 2016, has recommended dividend of 15 paise (7.5 percent) per Equity Share of face value of Rs. 2 each, subject to the approval of Shareholders at the ensuing Annual General Meeting.
Apr 26, 2016 at 14:40 | Source: PTI
With over 12 years of experience, Kalra joins Snapdeal after stints at Hindustan Unilever Ltd, GlaxoSmithKline Consumer Healthcare Ltd and Pepsico, Snapdeal said in a statement.
Apr 26, 2016 at 14:08 | Source: Moneycontrol.com
Aarti Drugs Ltd has informed BSE that the meeting of Board of Directors is scheduled to be held on May 05, 2016, inter alia, to consider, approve and take on record Audited Financial Results and Accounts for the quarter and year ended on March 31, 2016.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

Web Messenger

Platinum Member

369284 Followers

DLF  

Source:Wall Street Journal - By KHUSHITA VASANT MUMBAI -- The Bombay Stock Exchange will replace real-estate developer DLF Ltd. with Dr. Reddy's Laboratories Ltd. in its 30-share benchmark Sensitive Index. The exchange will also replace Glaxosmithkline Pharmaceuticals Ltd. from

2.09 PM Apr 23rd 2012

Web Messenger

Platinum Member

369284 Followers

Dr Reddys Labs  

Source:Wall Street Journal - By KHUSHITA VASANT MUMBAI -- The Bombay Stock Exchange will replace real-estate developer DLF Ltd. with Dr. Reddy's Laboratories Ltd. in its 30-share benchmark Sensitive Index. The exchange will also replace Glaxosmithkline Pharmaceuticals Ltd. from

2.09 PM Apr 23rd 2012

EQUITY UNCLE

Platinum Member

8326 Followers

GlaxoSmithKline  

Sell Glaxosmithkline Pharmaceuticals Ltd@3000, sl 3009, tgt 2980, 2970

10.25 AM Sep 10th

EQUITY UNCLE

Platinum Member

8326 Followers

GlaxoSmithKline  

Sell Glaxosmithkline Pharmaceuticals Ltd@ 2974, sl 2982, tgt 2954, 2939

3.51 AM Sep 6th

News across the web »
Feb 18, 2014 at 10:41 | Source: Economic Times
Feb 18, 2014 at 08:26 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.